Navigation Links
KnightStar® 330 Bi-Level® Ventilator

ProductsKnightStar® 330 Bi-Level® Ventilator
Company Puritan Bennett
Item KnightStar® 330 Bi-Level® Ventilator
Features 
  • Low 30 dBA sound output
  • Optional battery mode
  • Backup rate in A/C mode
  • Three selectable modes of ventilation
  • Internal alarms
  • Leak compensation
  • One-year warranty
  • Compatible with complete family of Puritan Bennett® CPAP interfaces, including the Breeze SleepGear CPAP™ Interface System
Description The KnightStar® 330 Ventilator is a blower-based, bi-level positive pressure ventilator system designed to treat spontaneously breathing patients weighing 30 kg or more. The KnightStar 330 can be used to treat respiratory insufficiency and/or obstructive sleep apnea in the home, hospital or other institutional setting. The KnightStar 330 Ventilator includes a 3-30 cm H2O pressure range, an LCD display, pressure ramp and delay settings, patient lockout mode, automatic altitude/leak compensation, built-in audible/visual alarms, adjustable pressure rise time, and inspiratory/expiratory breath trigger sensitivities.
Info Puritan Bennett
Customer Service: (800) 663-3336
Web site: http://www.sandmansleep.com/

Related medicine products :

1. GoodKnight® 425 Bi-Level® Device
2. AV80 Ventilator
3. Ventilator Filter with Flexible Coupler
4. Ventilator Filter with Flexible Coupler and Humidifier Tube
...c has been a key participant in the area of blood ...us Medtronic autotransfusion systems allowed clini...latelets, as well as to determine requirements for...ch plasma (PRP) for a small amount of autologous b...
RX HERCULINK® PLUS Biliary Stent System
Response Catheter
Fast-Cath™ Guiding Introducers
Medicine Products:
(Date:12/2/2009)...tailing plastic surgery procedures is now availabl...dates can view procedures and print out informatio... (PRWEB) December 2, 2009 -- Recovery..., has always been dedicated to providing resources...es, providing liposuction garments, breast augment...
(Date:12/2/2009)...chieves IBM Ready for LINUX designation and enhanc...mainframe and contemporary systems running Linux. ...ember 2, 2009 -- eCube Systems, a leader in legacy...nounced that it has achieved the IBM Ready for LIN...dleware. This mark certifies NXTera has met compa...
(Date:12/2/2009)...-- A randomized, controlled study comparing standa...eatment called percutaneous disc decompression for...reatments help patients in the short run, only dis...years later. Results of the study, the first of it... of the Radiological Society of North America (RSN...
(Date:12/2/2009)... comparing standard conservative therapy to a mini...decompression for painful herniated disc revealed ...ort run, only disc decompression kept patients pai..., the first of its kind, were presented today at t...orth America (RSNA). , Discs are sponge-like cus...
(Date:12/1/2009)...swire/ -- Reportlinker.com announces that a new ma...: ,, The Future of Central Nervous System Dise...etitive Benchmarking, Product Pipeline and Deals A...14/The-Future-of-Central-Nervous-System-Diseases-T...-Benchmarking-Product-Pipeline-and-Deals-Analysis....
Breaking Medicine News(10 mins):Health News:Online Compression Garments Retailer Introduces 3D Animation of Surgical Procedures 2Health News:eCube Delivers Linux on System z Support for NXTera High Performance Middleware 2Health News:eCube Delivers Linux on System z Support for NXTera High Performance Middleware 3Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 2Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 3Health News:Outpatient disc treatment gives long-term back pain relief 2Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 15Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 16Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 17Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 18Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 19Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 20Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 21Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 22
... Johnson &,Johnson will participate in the Eleven...ence on Tuesday, March 18th at the Loews Miami Bea...resident, Finance and Chief,Financial Officer, wil...,by accessing the Johnson & Johnson website at ht...
... Liu, CEO and Founder of,Ingenious Med and a pract...ntly appointed to serve on the Benchmarks Committe...Liu and the rest of the Benchmarks Committee,will ...arks for hospitalists nationwide in the areas of h...
...athon(R) is pleased to,announce a new Small Child ...der volume instrument with patent-pending NeuralHa...ealth care providers to measure,bladder volume non...ced BladderScan(R) BVI 9400 will make its official...
...rsity of Maryland study of whether people receive ...r race or ethnicity found that when whites and min...ason, they receive the same quality care in that h...ch 11 issue of Health Affairs. The study of 1841 h...
...ral candidate at Georgetown University, has been n...nor Society (Bouchet Society). Crawford is in the...ve Cancer Center, part of the Georgetown Universit...76). The Society aims to recognize outstanding sc...
...or Disease Control has awarded the Indiana Univers...ract with the possibility of nearly $10 million in...ability of local, state and regional entities to s... emergencies. , The funding will allow researcher...
Other Medicine News:Health News:Dr. Steve Liu, CEO of Ingenious Med, Joins Benchmarks Committee at SHM 2Health News:Verathon Inc. Launches Enhanced BladderScan(R) Bladder Volume Instrument With Small Child Mode 2Health News:Verathon Inc. Launches Enhanced BladderScan(R) Bladder Volume Instrument With Small Child Mode 3Health News:Minorities, whites get equal care in hospitals 2Health News:Georgetown U student selected for prestigious Bouchet Society 2Health News:Regenstrief Institute tapped by CDC to combat potentially catastrophic disease outbreaks 2
(Date:12/1/2009)... Wash., Dec. 1 SCOLR Pha...ember 20, 2009 it licensed to Chrono Nutraceutical...d sell four extended release dietary supplements u...latform. In addition, SCOLR granted Chrono rights...he United States on a nonexclusive basis. Chrono ...
(Date:12/1/2009)..., Dec. 1 CEL-SCI Corpora...pany and a developer of vaccines and therapeutics ...eases, announced today that it has retained the se...ization (CRO) to run CEL-SCI,s upcoming Phase III ...ancer with the Company,s lead product candidate, M...
(Date:12/1/2009)...LLE, N.C., Dec. 1 nContact Surgica...n of devices for minimally-invasive treatment for ...f a feasibility clinical trial designed to evaluat...nd catheter procedure, the convergent procedure, f...fibrillation (AF). This prospective, feasibility ...
Breaking Medicine Technology:SCOLR Pharma, Inc. Licenses Dietary Supplements 2SCOLR Pharma, Inc. Licenses Dietary Supplements 3CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 2CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 3nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 2Eli Lilly and Company Opens Eco Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation 5848 1Eli Lilly and Company Opens Eco Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation 5848 2Eli Lilly and Company Opens Eco Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation 5848 3Eli Lilly and Company Opens Eco Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation 5848 4Eli Lilly and Company Opens Eco Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation 5848 5Patent Attorneys McDaniel and Stipkala to Confer at Summit November 4 2009 60349 1House Healthcare Bill 3A Government Run Plan Other Key Provisions Undermine Goals of Access and Affordability 60346 1House Healthcare Bill 3A Government Run Plan Other Key Provisions Undermine Goals of Access and Affordability 60346 2House Healthcare Bill 3A Government Run Plan Other Key Provisions Undermine Goals of Access and Affordability 60346 3